Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe
欧洲利伐沙班长期上市后安全性研究项目面临的挑战和经验教训
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-081348
Brobert, Gunnar; Ruigomez, Ana; Schink, Tania; Voss, Annemarie; Herings, Ron; Smits, Elisabeth; Swart, Karin M A; Friberg, Leif; Balabanova, Yanina; Tarenz, Christine; Suzart-Woischnik, Kiliana; Soriano-Gabarró, Montse; Vora, Pareen; Homering, Martin; Dyszynski, Tomasz; Nagel, Gerd; Amaya, Pablo; García Rodríguez, Luis Alberto